Interleukin-11: Review of molecular, cell biology, and clinical use

Blood

Volumn 89, Issue 11, 1997, Pages 3897-3908

  Du, Xunxiang ^a   Williams, David A ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 11; LIPOPOLYSACCHARIDE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CYTOLOGY; DATA ANALYSIS; DNA DETERMINATION; GENE EXPRESSION; GENE MAPPING; HUMAN; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; THROMBOCYTOPOIESIS;

EID: 0030917254     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.3897     Document Type: Article

References (171)

1. Du XX, Williams DA: Interleukin-11: A multifunctional growth factor derived from the hematopoietic microenvironment. Blood 83:2030, 1994
2. Morris JC, Neben S, Bennett F, Finnerty H, Long A, Beiert DR, Kovacic S, McCoy JM, DiBlasio-Smith E, LaVallie ER, Caruso A, Calvetti J, Morris G, Weich N, Paul SR, Crossier PS, Turner KJ, Wood CR: Molecular cloning and characterization of murine interleukin-11. Exp Hematol 24:1369, 1996
3. McKinley D, Wu Q, Yang-Feng T, Yang Y-C: Genomic sequence and chromosomal location of human interleukin (IL)-11 gene. Genomics 13:814, 1992
4. Yang L, Yang Y-C: Regulation of interleukin (IL)-11 gene expression in IL-11 induced primate bone marrow stromal cells. J Biol Chem 269:32732, 1994
5. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM Jr, Leary AC, Sibley B, Clark SC, Williams DA, Yang Y-C: Molecular cloning of a cDNA encoding interleukin 11, a novel stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87:7512, 1990
6. Ohsumi J, Miyadai I, Ishikawa-Ohsumi H, Sakakibara S, Mita-Honjo K, Takiguchi T: Adipogenesis inhibitory factor. A novel inhibitory regulator of adipose conversion in bone marrow. FEBS Lett 288:13, 1991
7. Kawashima I, Ohsumi J, Mita-Honjo K, Shimoda-Takano K, Ishikawa H, Sakakibara S, Miyadai K, Takiguchi Y: Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. FEBS Lett 283:199, 1991
8. Czupryn M, Bennett F, Dube J, Grant K, Scobie H, Sookdeo H, McCoy JM: Alanine-scanning mutagenesis of human interieukin-11: Identification of regions important for biological activity. Ann NY Acad Sci 762:152, 1995
9. Czupryn MJ, McCoy JM, Scoble HA: Structure-function relationships in human interleukin-11. J Biol Chem 270:978, 1995
10. Du XX, Everett ET, Wang G, Lee W-H, Yang Z, Williams DA: Murine interleukin-11 (IL-11 ) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J Cell Physiol 168:362, 1996
11. Yang L, Steussy CN, Fuhrer DK, Hamilton J, Yang Y-C: Interleukin-11 mRNA stabilization in phorbol ester-stimulated primate bone marrow stromal cells. Mol Cell Biol 16:3300, 1996
12. Yang L, Yang Y-C: Heparin inhibits the expression of interleukin-11 and granulocyte-macrophage colony-stimulating factor in primate bone marrow stromal fibroblasts through mRNA destabilization. Blood 86:2526, 1995
13. Elias JA, Tang W, Horowitz MC: Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 136:489, 1995
14. Maier R, Ganu V, Lotz M: Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 268:21527, 1993
15. Elias JA, Zheng T, Einarsson O, Landry M, Trow T, Rebert N, Panuska J: Epithelial interleukin-11: Regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem 269:22261, 1994
16. Elias JA, Zheng T, Whiting NL, Trow TK, Merrill WW, Zitnik R, Ray P, Alderman EM: IL-1 and transforming growth factor-β regulation of fibroblast-derived IL-11. J Immunol 152:2421, 1994
17. Zheng T, Nathanson MH, Elias JA: Histamine augments cytoking-stimulated IL-11 production by human lung fibroblasts. J Immunol 153:4742, 1994
18. 0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci USA 89:4013, 1992
19. Musashi M, Yang Y-C, Paul SR, Clark SC, Sudo T, Ogawa M: Direct and synergistic effects of interleukin 11 on murine hematopoiesis in culture. Proc Natl Acad Sci USA 88:765, 1991
20. Tsuji K, Lyman SD, Sudo T, Clark SC, Ogawa M: Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 79:2855, 1992
21. Jacobsen FW, Keller JR, Ruscetti FW, Veiby OP, Jacobsen SE: Direct synergistic effects of IL-4 and IL-11 on the proliferation of primitive hematopoietic progenitor cells. Exp Hematol 23:990, 1995
22. Musashi M, Clark SC, Sudo T, Urdal DL, Ogawa M: Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood 78:1448, 1991
23. Hirayama F, Katayama N, Neben S, Donaldson D, Nickbarg EB, Clark SC, Ogawa M: Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. Blood 83:92, 1994
24. Ploemacher RE, van Soest PL, Boudewijn A, Neben S: Interleukin-12 enhances interleukin-3 dependent multilineage hematopoietic colony formation stimulated by interleukin-11 or steel factor. Leukemia 7:1374, 1993
25. Ploemacher RE, van Soest PL, Voorwinden H, Boudewijn A: Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hematopoietic stem cells in liquid culture. Leukemia 7:1381, 1993
26. Jacobsen SEW, Okkenhaug C, Veiby OP, Caput D, Ferrara P, Minty A: Interleukin 13: Novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 180:75, 1994
27. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S: Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Exp Hematol 21:1668, 1993
28. Jacobsen SE, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interations with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
29. Bertolini F, Lazzari L, Lauri E, Corsini C, Sirchia G: Cord blood plasma-mediated ex vivo expansion of hematopoietic progenitor cells. Bone Marrow Transplant 14:347, 1994
30. van de Ven C, Ishizawa L, Law P, Cairo MS: IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood versus adult bone marrow. Exp Hematol 23:1289, 1995
31. Ariyama Y, Misawa S, Sonoda Y: Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture. Stem Cells 13:404, 1995
32. Du XX, Williams DA: Update on development of interleukin-11. Curr Opin Hematol 2:182, 1995
33. Neben S, Donaldson D, Sieff C, Mauch P, Bodine D, Ferrara J, Yetz-Aldape J, Turner K: Synergistic effects of interleukin-11 with other growth factors on the expansion murine hematopoietic progenitors and maintenance of stem cells in liquid culture. Exp Hematol 22:353, 1994
34. Sato N, Sawada K, Koizumi K, Tarumi T. Leko M, Yasukouchi T, Yamaguchi M, Takahashi TA, Sekiguchi S, Koike T: In vitro expansion of human peripheral blood CD34+ cells. Blood 82:3600, 1993
35. Schibler KR, Yang Y-C, Christensen RD: Effect of interleukin-11 on cycling status and clonogenic maturation of fetal and adult hematopoietic protenitors. Blood 80:900, 1992
36. Tanaka R, Katayama N, Ohishi K, Mahumd N, Itoh R, Tanaka Y, Komada Y, Minami N, Sakurai M, Shirakawa S, Shiku H: Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood 86:73, 1995
37. Du XX, Scott D, Yang ZX, Cooper R, Xiao XL, Williams DA: Interleukin-11 stimulates multilineage progenitors, but not stem cells, in murine and human long-term marrow cultures. Blood 86:128, 1995
38. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30, 1996
39. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23:461, 1995
40. Holyoake TL, Freshney MG, McNair L, Parker A, N., Steward WP, Fitzsimons E, Graham GJ, Pragnell IB: Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplam and the ability to serially transplant marrow. Blood 87:4589, 1996
41. Hawley RG, Hawley TS, Fong AZC, Quinto C, Collins M, Leonard JP, Goldman SJ: Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin-11. Proc Natl Acad Sci USA 93:10297, 1996
42. Hangoc G, Yin T, Cooper S, Schendel P, Yang Y-C, Broxmeyer HE: In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood 81:965, 1993
43. Neben TY, Loebelenz J, Hayes L, McCarthy K, Stoudemire J, Schaub R, Goldman SJ: Recombinant human interleukin-11 stimulates megakaryocytopoesis and increases peripheral platelets in normal and splenectomized mice. Blood 81:901, 1993
44. Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Takasuki K: Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: Comparative study with interleukin-6. Br J Haematol 84:16, 1993
45. Mason L,Timony G, Perkin C, Badalone V, Bree A, Goldman S, Hayes L, Schaub R: Human recombinant interleukin-11 promotes maturation of bone marrow megakaryocytes in non-human primates: An electron microscopic study. Blood 82:69a, 1993 (abstr, suppl 1)
46. Broudy VC, Lin NL, Kaushansky K: Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719, 1995
47. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568, 1994
48. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C: Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92:3234, 1995
49. Tsukada J, Misago M, Ogawa R, Oda S, Morimoto I, Eto S, Kikuchi M: Synergism between serum factor(s) and erythropoietin in inducing murine megakaryocyte colony formation: The synergistic factor in serum is distinct from interleukin-11 and stem cell factor (c-kit ligand). Blood 81:866, 1993
50. Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Kato K, Takatsuki K: Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. Exp Hematol 20:1011, 1992
51. Bruno E, Briddell RA, Cooper RJ, Hoffman R: Effects of recombinant interleukin-11 on human megakaryocyte progenitor cells. Exp Hematol 19:378, 1991
52. Burstein SA, Mei RL, Henthorn J, Friese P, Turner K: Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol 153:305, 1992
53. Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H: Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 79:327, 1992
54. Bree A, Schlerman F, Timony G, McCarthy K, Stoudimire J: Phannacokinetics and thrombopoietic effects of recombinant human interleukin-11 (rhIL-11) in nonhuman primates and rodents. Blood 78:132a, 1991 (abstr, suppl 1)
55. Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewy J, Loesch D, Breeden E, Hoffman R, Beach KJ, Kuca B, Kaye J, Sledge GW Jr: A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87:3615, 1996
56. Orazi A, Cooper R, Tong J, Gordon MS, Battiato L, Sledge GW, Kaye J, Hoffman R: Recombinant human interleukin-11 (neumegaTM rhIL-11 growth factor; rhIL-11 ) has multiple profound effects on human hematopoiesis. Blood 82:369a, 1993 (abstr, suppl 1)
57. Sotiropoulos D, Adamson JW: Mechanism of action of interleukin 11 (IL-11) on in vitro megakaryopoiesis. Exp Hematol 24:1069, 1996
58. 57a. Weich NS, Wang A, Fitzgerald M, Giannotti J, Yetz-Aldape J, Leven RM, Turner KJ: Interleukin-11 receptor expression in megakaryocytes. Blood 88:60a, 1996
59. Ku H, Yonemura Y, Kaushansky K, Ogawa M: Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544, 1996
60. Quesniaux VFJ, Clark SC, Turner K, Fagg B: Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood 80:1218, 1992
61. Rodriguez MH, Arnaud S, Blanachet JP: IL-11 directly stimulates murine and human erythroid burst formation in semisolid cultures. Exp Hematol 23:545, 1995
62. de Haan G, Dontje B, Engael C, Loeffler M, Nijhof W: In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis. Br J Haematol 90:783, 1995
63. Cairo MS, Plunkett JM, Nguyen A, Schendel P, Van de ven C: Effect of interleukin-11 with and without granulocyte colonystimulating factor on in vivo neonatal rat hematopoiesis: Induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colonystimulating factor. Pediatr Res 34:56, 1993
64. Cairo MS, Plunkett JM, Schendel P, Van de ven C: The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: Significant enhancement of the absolute neutrophil count. Exp Hematol 22:1118, 1994
65. Hirayama F, Clark SC, Ogawa M: Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1 alpha. Proc Natl Acad Sci USA 91:469, 1994
66. Hirayama F, Shin J-P, Awgulewitsch A, Warr GW, Clark SC, Ogawa M: Clonal proliferation of murine Iymphohemopoietic progenitors in culture. Proc Natl Acad Sci USA 89:5907, 1992
67. Fujimoto K, Lyman SD, Hirayama F, Ogawa M: Isolation and characterization of primitive hematopoietic progenitors of murine fetal liver. Exp Hematol 24:285, 1996
68. Kee BL, Cumano A, Iscove NN, Paige CJ: Stromal cell independent growth of bipotent B cell-macrophage precursors from murine fetal liver. Int Immunol 6:401, 1994
69. Neben T, Donaldson D, Fitz L, Calvetti J, Neben T, Turner K, Hirayama F, Ogawa M: Interleukin-4 (1L-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development. Exp Hematol 24:783, 1996
70. Anderson KC, Morimoto C, Paul SR, Chauhan D, Williams D, Cochran M, Barut BA: Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood 80:2797, 1992
71. Yin T, Schendel P, Yu-Chung Y: Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin-11. J Exp Med 175:211, 1992
72. Paul SR, Yang Y-C, Donahue RE, Goldring S, Williams DA: Stromal cell-associated hematopoiesis immortalization and characterization of a primate bone marrow-derived Stromal cell line. Blood 77:1723, 1991
73. Thalmeier K, Meissner P, Reisbach G, Hultner L, Mortensen BT, Brechtel A, Oostendorp RA, Dormer P: Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines. Exp Hematol 24:1, 1996
74. Keller DC, Du XX, Srour EF, Hoffman R, Williams DA: Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in long term marrow cultures. Blood 82:1428, 1993
75. Krieger MS, Nissen C, Wodnar-Filipowicz A: Stem-cell factor in aplastic anemia: In vitro expression in bone marrow stroma and fibroblast cultures. Eur J Haematol 54:262, 1995
76. Schmitz B, Thiele J, Witte O, Kaufmann R, Wickenhauser C, Fischer R: Influence of cytokines (IL-1a, IL-3, IL-11, GM-CSF) on megakaryocyte-fibroblast interactions in normal human bone marrow. Eur J Haematol 55:24, 1995
77. Wickenhauser C, Hillienhof A, Jungheim K, Lorenzen J, Ruskowski H, Hansmann ML, Thiele J, Fischer R: Detection and quantification of transforming growth factor beta (TGF-b) and platelet-derived growth factor (PDGF) release by normal human megakaryocytes. Leukemia 9:310, 1995
78. Mauch P, Lamont C, Neben TY, Quinto C, Goldman SJ, Witsell A: Hematopoietic stem cells in the blood after stem cell factor and interleukin-11 administration: Evidence for different mechanisms of mobilization. Blood 86:4673, 1995
79. Peterson RL, Trepicchio WL, Bozza MM, Wang L, Dorner AJ: G1 growth arrest and reduced proliferation of intestinal eqithelial cells induced by rhIL-11 may mediate protection against mucositis. Blood 86:311a, 1995 (abstr, suppl 1)
80. Du XX, Doerschuk CM, Orazi A, Williams DA: A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83:33, 1994
81. Booth C, Potten CS: Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 28:581, 1995
82. Peterson RL, Bozza MM, Dorner AJ: Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma phosphorylation. Am J Pathol 149:895, 1996
83. Baynes RD, Cook JD, Keith J: Interleukin-11 enhances gastrointestinal absorption of iron in rats. Br J Haematol 91:230, 1995
84. Girasole G, Passeri G, Jilka RL, Manolagas SC: Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 93:1516, 1994
85. Hughes FJ, Howells GL: Interleukin-11 inhibits bone formation in vitro. Calcif Tissue Int 53:362, 1993
86. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N: Modulation of osteoclast differentiation by local factors. Bone 17:87S, 1995 (suppl 2)
87. Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ: The role of gp130-mediated signals in osteoclast development: Regulation of interleukin-11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 183:2581, 1996
88. Mehler MF, Rozental R, Dougherty M, Spray DC, Kessler JA: Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362:62, 1993
89. Fann M, Patterson PH: Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc Natl Acad Sci USA 91:43, 1994
90. Rameshwar P, Ganea D, Gascon P: In vitro stimulatory effect of substance P on hematopoiesis. Blood 81:391, 1993
91. Rameshwar P, Ganea D, Gascon P: Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J Immunol 152:4044, 1994
92. Rameshwar P, Gascon P: Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86:482, 1995
93. Hart RP, Shadiack AM, Jonakait GM: Substance P gene expression is regulated by interleukin-1 in cultured sympathetic ganglia. J Neuroscience Res 29:282, 1991
94. Reichlin S: Neuroendocrine-immune interactions. N Engl J Med 329:1246, 1993
95. Weihe E, Nohr D, Michel S, Muller S, Zentel HJ, Fink T, Krekel J: Molecular anatomy of the neuro-immune connection. Int J Neurosci 59:1, 1991
96. Baumann H, Schendel P: Imerleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 266:20424, 1991
97. Fukuda Y, Sassa S: Effect of interleukin-11 on the levels of mRNAs encoding heme oxygenase and haptoglobin in human HepG2 hepatoma cells. Biochem Biophys Res Commun 193:297, 1993
98. Ohsumi J, Miyadai K, Kawashima I, Sakakibara S, Yamaguchi J, Itoh Y: Regulation of lipoprotein lipase synthesis in 3T3-Ll adipocytes by interleukin-11/adipogenesis inhibitory factor. Biochem Mol Biol Int 32:705, 1994
99. Lopez-Valpuesta FJ, Myers RD: Fever produced by interleukin-11 (IL-11) injected into the anterior hypothalamic pre-optic area of the rat is antagonized by indomethacin. Neuropharmacology 33:989, 1994
100. Roeb E, Graeve L, Hoffmann R, Decker K, Edwards DR, Heinrich PR: Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 18:1437, 1993
101. 99a. Trepicchio WL, Bozza M, Pedneault G, Domer AJ: Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 157:3627, 1996
102. 99b. Redlich CA, Gao X, Rockwell S, Kelley M, Elias JA: IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 157:1705, 1996
103. Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD: LIFRβ and gp 130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260:1805, 1993
104. Hilton DJ, Hilton AA, Raicevic A, Rakar S, Harrison-Smith M, Gough NM, Begley CG, Metcalf D, Nicola NA, Willson TA: Cloning of a murine IL-11 receptor alpha-chain; requirement for gpl30 for high affinity binding and signal transduction. EMBO J 13:4765, 1994
105. Nandurkar HH, Hilton D, Nathan P, Wilson T, Nicola N, Begley CG: The human IL-11 receptor require gp130 for signaling: Demonstration by molecular cloning of the receptor. Oncogene 12:585, 1996
106. Cherel M, Sorel M, Lebeau B, Dubois S, Moreau JF, Bataille R, Minvielle S, Jacques Y: Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 86:2534, 1995
107. Cherel M, Sorel M, Apiou F, Lebeau B, Dubois S, Jacques Y, Minvielle S: The human interleukin-11 receptor alpha gene (IL 11RA): Genomic organization and chromosone mapping. Genomics 32:49, 1996
108. Robb L, Hilton DJ, Willson TA, Begley CG: Structural analysis of the gene encoding the murine interleukin-11 receptor alpha chain and a related locus. J Biol Chem 271:13754, 1996
109. Fourcin M, Chevalier S, Lebrun J-J, Kelly P, Pouplard A, Wijdenes J, Gascan H: Involvement of gp 130/interleukin-6 receptor transducing component in interleukin-11 receptor. Eur J lmmunol 24:277, 1994
110. Nishimoto N, Ogata A, Shima Y, Tani Y, Ogawa H, Nakagawa M, Sugiyama H, Yoshizaki K, Kishimoto T: Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, GP130. J Exp Med 179:1343, 1994
111. Yin T, Taga T, Tsang ML-S, Yasukawa K, Kishimoto T, Yang Y-C: Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J lmmunol 151:2555, 1993
112. Zhang X-G, Gu J-L Lu Z-Y, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B: Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer GP130. J Exp Med 179:1337, 1994
113. Yang Y-C, Yin T: Interleukin-11 and its receptor. Biofactors 4:15, 1992
114. Yin T, Miyazawa K, Yang YC: Characterazation of interlukin-11 receptor and protein tyrosine phosphorylation induced by interluekin-11 in mouse 3T3-L1 cells. J Biol Chem 267:8347, 1992
115. Yin T, Yang Y-C: Interleukin-11 mediated signal transduction pathways: Comparison with those of interleukin-6, in Moody TW (ed): Growth Factors, Peptides, and Receptors. New York, NY, Plenum, 1993, p 323
116. Berger LC, Hawley TS, Lust JS, Goldman SJ, Hawley RG: Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11. Biochem Biophys Res Commun 202:596, 1994
117. Yin T, Yasukawa K, Taga T, Kishimoto T, Yang Y-C: Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. Exp Hematol 22:467, 1994
118. Wang XY, Fuhrer DK, Marshall MS, Yang YC: Interleukin-11 induces complex formation of Grb2, Fyn, and JAK2 in 3T3L1 cells. J Biol Chem 270:27999, 1995
119. Yin T, Yang Y-C: Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6. leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J Biol Chem 269:3731, 1994
120. Yang YC, Yin T: Interleukin (IL)-11 -mediated signal transduction. Ann NY Acad Sci 762:31, 1995
121. Fuhrer DK, Yang YC: Activation of src-family protein tyrosine kinases and phosphatidylmositol 3-kinase in 3t3-L1 mouse preadipocytes by interleukin-11. Exp Hematol 24:195, 1996
122. Fuhrer DK, Feng GS, Yang YC: Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes. J Biol Chem 270:24826, 1995
123. Siddiqui RA, Yang YC: Interleukin-11 induces phosphatidic acid formation and activates MAP kinase in mouse 3T3-L1 cells. Cell Signal 7:247, 1995
124. Wegenka UM, Lutticken C, Buschmann J, Yuan J, Lottspeich F, Muller-Esterl W, Schindler C, Roeb E, Heinrich PC, Horn F: The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol Cell Biol 14:3186, 1994
125. Du XX, Neben T, Goldman S, Williams DA: Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: Acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81:27, 1993
126. Du XX, Keller D, Goldman S, Williams DA: Functional effects of interleukin-11 treatment in vivo following bone marrow transplantation (BMT) and combined modality therapy in mice. Exp Hematol 20:768, 1992
127. Du XX, Keller DC, Maze R, Williams DA: Comparative effects of in vivo treatment using interleukin-11 and stem cell factor on reconstitution in mice following bone marrow transplantation. Blood 82:1016, 1993
128. Paul SR, Hayes LL, Palmer R, Morris GE, Neben TY, Loebelenz J, Pedneault G, Brooks J, Blue I, Moore MAS, Muench M, Turner KJ, Schaub R, Goldman SJ, Wood CR: Interleukin-11 expression in donor bone marrow cells improves hematological reconstitution in Iethally irradicated recipient mice. Exp Hematol 22:295, 1994
129. Hawley RG: Interleukin-6-type cytokines in myeloproliferative disease. Ann NY Acad Sci 762:294, 1995
130. Hawley RG, Fong AZC, Ngan BY, de Lanux VM, Clark SC, Hawley TS: Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras. J Exp Med 178:1175, 1993
131. Nash RA, Siedel K, Storb R, Slichter S, Schuening FG, Appelbaum FR, Becker AB, Bolles L, Deeg HJ, Graham T, Hackman RC, Burstein SA: Effects of rhIL-11 on normal dogs and after sublethal radiation. Exp Hematol 23:389, 1995
132. de Haan G, Dontje B, Engel C, Loeffler M, Nijhof W: Prophylactic pretreatmeant of mice with hematopoietic growth factors induces expansion of primitive cell compartments and results in protection against 5-fluorouracil-induced toxicity. Blood 87:4581, 1996
133. Goldman SJ: Preclinical biology of interleukin 11 : A multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells 13:462, 1995
134. Keith JCJ, Albert L, Sonis ST, Pfeiffer CJ, Schaub RG: IL-11, a pleiotropic cytokine: Exciting new effects of IL-11 on gastrointestional mucosal biology. Stem Cells 12:79, 1994
135. Maze R, Moritz T, Williams DA: Increased survival and multilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11 (IL-11). Cancer Res 54:4947, 1994
136. Sonis S, Muska A, O'Brien J, Van Vugt A, Langer-Safer P, Keith J: Alterations in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur J Cancer 31B:261, 1995
137. Orazi A, Du XX, Yang Z, Kashai M, Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75:33, 1996
138. Potten CS: Interleukin-11 protects the donogenic stem cells in murine small intestinal crypts from impairment of their reproductive capacity by radiation, lnt J Cancer 62:356, 1995
139. Du XX, Liu X, Yang Z, Orazi A, Rescorla FJ, Grosfeld JL, Williams DA: The protective effects of interleukin-11 (IL-11) in a murine model of ischemic bowel necrosis. Am J Physiol 272:545, 1997
140. Schindel D, Maze R, Liu Q, Williams DA, Grosfeld J: Interleukin-11 improves survival and reduces bacterial translocation and bone marrow suppression in burned mice. J Pediatr Surg 32:312, 1997
141. Liu Q, Du XX, Schindel DT, Yang ZX, Rescorla FJ, Williams DA, Grosfeld JL: Trophic effects of interleukin-11 in rats with experimental short bowel syndrome. J Pediatr Surg 31:1047, 1996
142. Barton BE, Shortall J, Jackson JV: Interleukin-6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun 64:714, 1996
143. Chang M, Williams A, Ishizawa L, Knoppel A, Van de ven C, Cairo MS: Role of interleukin-11 (IL-11) during experimental group B streptococcal (GBS) sepsis in neonatal rats: Prophylactic use of IL-11 improves survival and enhances platelet recovery. Blood 84:477a, 1994 (abstr, suppl 1)
144. Misra BR, Ferranti TJ, Keith JC Jr, Donnelly LH, Erickson JE, Schaub RG: Recombinant human interleukin-11 prevents hypotension in LPS-treated anesthetized rabbits. J Endotox Res 3:297, 1996
145. Trepicchio WL, Bozza M, Dorner AJ: Recombinant human interleukin-11 attenuates the proinflammatory response through regulation of cytokine gene expression. Exp Hematol 24:1099, 1996
146. Hu JP, Cesano A, Santoli D, Clark SC, Hoang T: Effects of interleukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. Blood 81:1586, 1993
147. Lemoli RM, Fogli M, Fortuna A, Amabile M, Zucchini P, Grande A, Martinelli G, Visani G, Ferrari S, Tura S: Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells. Br J Haematol 91:319, 1995
148. Kobayashi S, Teramura M, Sugawara I, Oshimi K, Mizoguchi H: Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood 81:889, 1993
149. Paul SR, Barut BA, Bennett F, Cochran MA, Anderson KC: Lack of a role of interleukin 11 in the growth of multiple myeloma. Leuk Res 16:247, 1992
150. Burger R, Gramatzki M: Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11. J Immunol Methods 158:147, 1993
151. Lu Z-Y, Zhang X-G, Gu Z-J, Yasukawa K, Amiot M, Etrillard M, Bataille R, Klein B: A highly sensitive quantitative bioassay for human interleukin-11. J Immunol Methods 173:19, 1994
152. Yin T, Yang Y-C: Protein tyrosine phosphorylation and activation of primary response genes by interleukin 11 in B9-TY1 cells. Cell Growth Diff 4:603, 1993
153. Tani Y, Nishimoto N, Ogata A, Shima Y, Yoshizaki K, Kishimoto T: Gp 130 in human myeloma/plasmacytoma. Curr Top Microbiol Immunol 194:229, 1995
154. Lu ZY, Gu ZJ, Zhang XG, Wijdenes J, Neddermann P, Rossi JF, Klein B: Interleukin-10 induces interleukin-11 responsiveness in human myeloma cell lines. FEBS Lett 377:515, 1995
155. Gu ZJ, Wijdenes J, Zhang XG, Hallet MM, Clement C, Klein B: Anti-gp 130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M. J Immunol Meth 190:21, 1996
156. Brosh N, Sternberg J, Honigwachs-Sha'anani J, Lee BC, Shav-Tal Y, Tzehoval E, Shulman LM, Toledo J, Hacham Y, Carmi P: The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11 : Identification as a stroma-derived activin A. J Biol Chem 270:29594, 1995
157. Ault KA, Mitchell J, Knowles C, Clendaniel A, Egan A, Loewy J, Garnick MB, Kaye JA: Recombinant human interleukin eleven (neumegaTM rhIL-11 growth factor) increases plasma volume and decreases urine sodium excretion in normal human subjects. Blood 84:276a, 1994 (abstr, suppl 1)
158. Champlin RE, Mehra R, Kaye JA, Woodin MB, Geisler D, Davis M, Wood J, Andersson B, vanBesien K, Gajewski J, Przepiorka D, Deisseroth AB: Recombinant human interleukin eleven (rhIL-11) following autologous BMT for breast cancer. Blood 84:395a, 1994 (abstr, suppl 1)
159. Cairo MS, Davenport V, Reaman G, Laver J, Kreissman S, Blazar B, Berg S, Patterson F, Kaye J: Accelerated hematopoietic recovery with rhIL-11 following ifosfamide, carboplatin. and etoposide administration in children with solid tumor or lymphoma: Prelimary results of a phase I/I1 trial. Exp Hematol 24:1104, 1996
160. Isaacs C, Robert N, Loewy J, Kaye JA, Participating Investigators: Neumega® (rhIL-11) prevents platelet transfusions in up to 4 cycles of dose-intense chemotherapy in women with breast cancer. Blood 88:448a, 1996 (abstr, suppl 1)
161. Tepler I, Elias L, Smith W II, Hussein M, Rosen G, Chang AY-C, Moore JO,
162. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994
163. Bartley TD, Bogenberger J, Hint P, Li Y-S, Lu HS, Martin F, Chang M-S, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu R-Y, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNich J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey Tl, Grouse J, Garcia A, Xu W, del Castillo J, Biron J, Cole S, Hu C-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and deveolopment factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
164. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grand FJ, Helpel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osbom SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994
165. Kuter DJ, Beeler DL, Rosenberg RD: The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 91:11104, 1994
166. Murphy GMJ, Bitting L, Majewska A, Schmidt K, Song Y, Wood CR: Expression of interleukin-11 and its encoding mRNA by glioblastoma cells. Neurosci Lett 196:153, 1995
167. Rier SE, Parsons AK, Becker JL: Altered interleukin-6 production by peritoneal leukocytes from patients with endomelriosis. Fertil Steril 61:294, 1994
168. Noble LS, Simpson ER, Johns A, Bulun SE: Aromatase expression in endometriosis. J Clin Endocrinol Metab 81:174, 1996
169. Longley J, Rochester C, Tyrrell L, Einarsson O, Elias J: Interleukin-11 (IL-11) in normal skin and sarcoidosis. J Invest Dermatol 100:524, 1993
170. Paglia D, Oran A, Lu C, Kerbel RS, Sauder DN, McKenzie RC: Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIF. IL-6, and IL11 are not coregulated. J Interferon Cytokin Res 15:455, 1995
171. Bank S, Sninsky C, Robinson M, Katz S, Singleton J, Miner P, Safdi M, Galandiuk S, Hanauer S, Varilek G, Sands B, Buchman A, Rogers V, Salzberg B, Cai B, Rogge H, Schwertschlag U: Safety and activity evaluation of rhIL-11 in subjects with active Crohn's disease. Shock 7:520, 1997